| 000 | 01891 a2200565 4500 | ||
|---|---|---|---|
| 005 | 20250513081700.0 | ||
| 264 | 0 | _c19930525 | |
| 008 | 199305s 0 0 eng d | ||
| 022 | _a1042-8194 | ||
| 024 | 7 |
_a10.3109/10428199309148514 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMusto, P | |
| 245 | 0 | 0 |
_aIncreased risk of neurological relapse in acute lymphoblastic leukemias with high levels of cerebrospinal fluid thymidine kinase at diagnosis. _h[electronic resource] |
| 260 |
_bLeukemia & lymphoma _cJan 1993 |
||
| 300 |
_a121-4 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xcerebrospinal fluid |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aCranial Irradiation |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInjections, Spinal |
| 650 | 0 | 4 |
_aLeukemic Infiltration _xdrug therapy |
| 650 | 0 | 4 | _aLeukocyte Count |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMeninges _xpathology |
| 650 | 0 | 4 |
_aMethotrexate _xadministration & dosage |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasm Proteins _xcerebrospinal fluid |
| 650 | 0 | 4 |
_aPrecursor Cell Lymphoblastic Leukemia-Lymphoma _xdrug therapy |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aThymidine Kinase _xcerebrospinal fluid |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aModoni, S | |
| 700 | 1 | _aLadogana, S | |
| 700 | 1 | _aSalcuni, G | |
| 700 | 1 | _aFusilli, S | |
| 700 | 1 | _aCarotenuto, M | |
| 773 | 0 |
_tLeukemia & lymphoma _gvol. 9 _gno. 1-2 _gp. 121-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3109/10428199309148514 _zAvailable from publisher's website |
| 999 |
_c8476461 _d8476461 |
||